[Form 4] Life360, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Life360, Inc. director Charles J. Prober reported an exercise-and-sell transaction involving 7,930 shares. On 2026-03-13, he exercised stock options to acquire 7,930 shares of common stock at an exercise price of $11.18 per share, then sold 7,930 shares of common stock at $41.40 per share in an open-market transaction.
The activity was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on 2025-03-14. After these transactions, Prober directly held 105,456 shares of common stock, including 679 restricted stock units that each represent a right to receive one share upon vesting.
Positive
- None.
Negative
- None.
Insights
Routine option exercise-and-sale by a director under a 10b5-1 plan.
Director Charles J. Prober exercised stock options for 7,930 shares at an exercise price of $11.18 and sold 7,930 shares at $41.40 on 2026-03-13. This is a classic exercise-and-sell pattern where derivative awards are converted into common stock and then into cash.
The filing specifies that the sale occurred under a Rule 10b5-1 trading plan adopted on 2025-03-14, meaning the trades followed preset instructions rather than ad hoc decisions. Following the transactions, Prober still directly holds 105,456 shares, including 679 restricted stock units, suggesting the sale represents only a portion of his overall equity exposure.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 7,930 | $0.00 | -- |
| Exercise | Common stock | 7,930 | $11.18 | $89K |
| Sale | Common stock | 7,930 | $41.40 | $328K |
Footnotes (1)
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date